Google Ventures Wants to Be A Big Player in Biotech

Home/Financial/Google Ventures Wants to Be A Big Player in Biotech

Google Ventures Wants to Be A Big Player in Biotech

Intro from feature article about Google Ventures jumping into healthcare and biotech from Caroline Chen of Bloomberg:

“Bill Maris, founder of Google Ventures, has a purse full of Alphabet Inc.’s cash and a mandate to spend it on big ideas. Having made a name in tech investments, he now wants his firm to be known as a big player in health care and biotech.

Bill Maris

Bill Maris (Michael Nagle/Bloomberg)

Rebranded as GV in December, the venture capital fund has $2.4 billion under management and last year about a third of its investments were in health care, Maris said. Compare that with storied Silicon Valley venture firm Andreessen Horowitz, which in November announced a $200 million health fund limited to tech-based approaches. GV is going further, making bets in sectors overseen by the Food and Drug Administration like drugs and medical devices. Maris says he’s willing to deal with long schedules and regulatory hiccups.

“I care that the technology works,” Maris said. “The rest will follow.”

That wide spectrum of health investments and willingness to take on regulatory risk is unusual.”

Full article

February 12th, 2016|

Leave A Comment

X